Breaking News Instant updates and real-time market news.

HCA

HCA Healthcare

$131.92

-1.86 (-1.39%)

07:37
09/20/18
09/20
07:37
09/20/18
07:37

HCA Healthcare price target raised to $155 from $135 at Jefferies

Jefferies analyst Brian Tanquilut raised his price target for HCA Healthcare to $155 saying the stock "still has room to run" despite the year-to-date rally. HCA is well positioned to deliver organic revenue and EBITDA growth acceleration in the next few years, as it benefits from economic/population growth in its markets, strategic investments and selective acquisitions, Tanquilut tells investors in a research note. Further, the analyst believes "easy" Q3 comps and the tailwind from an upcoming Medicare rate bump "should provide incremental stock momentum." He keeps a Buy rating on the shares.

HCA HCA Healthcare
$131.92

-1.86 (-1.39%)

09/10/18
RBCM
09/10/18
NO CHANGE
Target $150
RBCM
Outperform
HCA Healthcare price target raised to $150 from $130 at RBC Capital
RBC Capital analyst Frank Morgan raised his price target on HCA Healthcare to $150 and kept his Outperform rating, citing the financial contribution from "several pending transitions" that are yet to close. The analyst highlights the $1.5B deal to acquire Mission Health in North Carolina and North Cypress in Houston, stating that these will add to the company's anticipated tailwinds in 2019. Morgan is also positive on the "improved performance" from HCA Heathcare's other Houston-area hospitals that were acquired from Tenet last year.
09/06/18
ARGS
09/06/18
NO CHANGE
Target $150
ARGS
Buy
HCA Healthcare price target raised to $150 from $116 at Argus
Argus analyst Jasper Hellweg raised his price target on HCA Healthcare to $150 and kept his Buy rating, saying the company's recent acquisition of Mission Heath in North Carolina strengthens its regional presence. The analyst also cites the managements expectations of healthcare services demand rising 2.0-2.5% annually on "population growth, strong economic conditions, higher medical utilization, and an increase in the number of patients with chronic conditions." Hellweg raises his FY18 EPS view on HCA Healthcare to $9.24 from $8.74, adding that its valuation is "attractive" at 14.4-times expected FY18 earnings vs. 17.5-times peer group average.
09/05/18
BMOC
09/05/18
NO CHANGE
Target $155
BMOC
Outperform
HCA Healthcare price target raised to $155 from $145 at BMO Capital
BMO Capital analyst Matt Borsch raised his price target on HCA Healthcare to $155 and kept his Outperform rating after its announcement to acquire Mission Health - a 7-facility North Carolina health system. The analyst notes that the deal meets HCA's criteria of buying "premium properties in growing markets" and expanding its geographic scope. Borsch adds that while the acquisition is expected to be neutral to near-term earnings, it will be accretive longer term once the facilities are brought up to HCA's high-teen EBITDA margin range.
09/04/18
RHCO
09/04/18
NO CHANGE
Target $150
RHCO
Buy
HCA Healthcare price target raised to $150 from $145 at SunTrust
SunTrust analyst David MacDonald raised his price target on HCA Healthcare to $150 and kept his Buy rating after its announcement to acquire Mission Health for $1.5B. The analyst notes that the deal will give the company its "first entrance into the North Carolina market with seven facilities including the sizable 763-bed Mission Hospital in Asheville and six smaller locations in the western part of the state" and reflects its ongoing strategy of growth through expansion into new strategic markets. MacDonald is also positive on HCA's "clean" balance sheet and "robust" free cash flow generation.

TODAY'S FREE FLY STORIES

HGV

Hilton Grand Vacations

$29.52

-0.09 (-0.30%)

16:33
11/19/18
11/19
16:33
11/19/18
16:33
Hot Stocks
Hilton Grand Vacations names Gordon Gurnik as COO »

Hilton Grand Vacations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

LB

L Brands

$34.53

-0.75 (-2.13%)

16:33
11/19/18
11/19
16:33
11/19/18
16:33
Hot Stocks
Breaking Hot Stocks news story on L Brands »

L Brands reports Q3 SSS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

LB

L Brands

$34.53

-0.75 (-2.13%)

16:32
11/19/18
11/19
16:32
11/19/18
16:32
Hot Stocks
L Brands to cut annual dividend to $1.20 from $2.40 »

After extensive review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

T

AT&T

$30.34

0.04 (0.13%)

16:32
11/19/18
11/19
16:32
11/19/18
16:32
Periodicals
CNN abandons WH suit after Acosta's press pass restored, WP says »

CNN has withdrawn its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 03

    Dec

YUM

Yum! Brands

$88.15

-0.77 (-0.87%)

, TGT

Target

$77.77

-1.9 (-2.38%)

16:31
11/19/18
11/19
16:31
11/19/18
16:31
Hot Stocks
Yum! Brands names Brian Cornell as non-executive Chairman of Board »

Yum! Brands (YUM)…

YUM

Yum! Brands

$88.15

-0.77 (-0.87%)

TGT

Target

$77.77

-1.9 (-2.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

LB

L Brands

$34.53

-0.75 (-2.13%)

16:31
11/19/18
11/19
16:31
11/19/18
16:31
Earnings
L Brands reports Q3 adjusted EPS 16c, consensus 15c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NUAN

Nuance

$16.27

-0.61 (-3.61%)

16:30
11/19/18
11/19
16:30
11/19/18
16:30
Earnings
Nuance sees FY19 EPS $1.02-$1.21, consensus $1.23 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

16:30
11/19/18
11/19
16:30
11/19/18
16:30
Options
Preliminary option volume of 20.0M today »

Preliminary option volume…

NUAN

Nuance

$16.27

-0.61 (-3.61%)

16:30
11/19/18
11/19
16:30
11/19/18
16:30
Hot Stocks
Breaking Hot Stocks news story on Nuance 

Nuance trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NUAN

Nuance

$16.27

-0.61 (-3.61%)

16:28
11/19/18
11/19
16:28
11/19/18
16:28
Earnings
Nuance sees Q1 EPS 27c-29c, consensus 28c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

LMB

Limbach Holding

$5.89

-0.17 (-2.81%)

16:27
11/19/18
11/19
16:27
11/19/18
16:27
Earnings
Limbach backs FY18 revenue view $530M-$550M, consensus $541.82M »

Backs FY18 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

PSTG

Pure Storage

$17.56

-1.56 (-8.16%)

16:27
11/19/18
11/19
16:27
11/19/18
16:27
Earnings
Pure Storage raises FY19 revenue view to $1.376B-$1.384B from $1.35B-$1.38B »

FY19 consensus $1.37B. …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

LMB

Limbach Holding

$5.89

-0.17 (-2.81%)

16:26
11/19/18
11/19
16:26
11/19/18
16:26
Earnings
Limbach reports Q3 EPS (46c) vs (12c) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

EBS

Emergent BioSolutions

$69.73

-1.36 (-1.91%)

16:26
11/19/18
11/19
16:26
11/19/18
16:26
Hot Stocks
Emergent BioSolutions and VLAS report 'positive' trial results for Zika vaccine »

Emergent BioSolutions and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 12

    Dec

NVLN

Novelion Therapeutics

$1.00

0.0192 (1.96%)

16:25
11/19/18
11/19
16:25
11/19/18
16:25
Hot Stocks
Breaking Hot Stocks news story on Novelion Therapeutics »

NB Public Equity reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTS

Akoustis

$4.55

-0.14 (-2.99%)

16:24
11/19/18
11/19
16:24
11/19/18
16:24
Hot Stocks
Akoustis announces first 5.2 HGz WiFi pre-production order »

Akoustis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 11

    Dec

  • 12

    Dec

AAPL

Apple

$185.80

-7.62 (-3.94%)

, FB

Facebook

$131.62

-7.93 (-5.68%)

16:24
11/19/18
11/19
16:24
11/19/18
16:24
OnTheFly
Fly Intel: Wall Street's top stories for Monday »

Stocks opened in negative…

AAPL

Apple

$185.80

-7.62 (-3.94%)

FB

Facebook

$131.62

-7.93 (-5.68%)

NSANY

Nissan

$0.00

(0.00%)

REN

Resolute Energy

$34.72

4.21 (13.80%)

XEC

Cimarex Energy

$88.03

-0.6 (-0.68%)

NIO

NIO Inc.

$7.81

0.63 (8.77%)

CFX

Colfax

$23.72

-4.285 (-15.30%)

BX

Blackstone

$31.78

-0.7 (-2.16%)

MDLZ

Mondelez

$44.45

0.17 (0.38%)

CPB

Campbell Soup

$38.47

-0.17 (-0.44%)

JD

JD.com

$21.09

-1.95 (-8.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 28

    Nov

  • 29

    Nov

  • 04

    Dec

DERM

Dermira

$9.73

0.04 (0.41%)

16:22
11/19/18
11/19
16:22
11/19/18
16:22
Upgrade
Dermira rating change  »

Dermira assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRI

Thomson Reuters

$48.42

-0.58 (-1.18%)

16:20
11/19/18
11/19
16:20
11/19/18
16:20
Hot Stocks
Thomson Reuters receives shareholder approval for return of capital transaction »

Thomson Reuters announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 04

    Dec

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
11/19/18
11/19
16:20
11/19/18
16:20
Options
Closing CBOE SPX and VIX Index summary for November 19th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUS

Bellus Health

$0.00

(0.00%)

16:19
11/19/18
11/19
16:19
11/19/18
16:19
Conference/Events
Bellus Health to host conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORPN

Bio Blast Pharma

$1.19

-0.02 (-1.65%)

16:18
11/19/18
11/19
16:18
11/19/18
16:18
Hot Stocks
Bio Blast Pharma to acquire Enlivex Therapeutics »

Bioblast Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCRH

QCR Holdings

$36.85

-0.34 (-0.91%)

16:18
11/19/18
11/19
16:18
11/19/18
16:18
Hot Stocks
QCR Holdings says Douglas Hultquist will retire as CEO, Helling to succeed »

QCR Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARAY

Accuray

$4.45

-0.27 (-5.72%)

, DHR

Danaher

$101.29

-1.95 (-1.89%)

16:18
11/19/18
11/19
16:18
11/19/18
16:18
Hot Stocks
Accuray names Shig Hamamatsu as CFO, effective immediately »

Accuray (ARAY) announced…

ARAY

Accuray

$4.45

-0.27 (-5.72%)

DHR

Danaher

$101.29

-1.95 (-1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 30

    Nov

  • 13

    Dec

JACK

Jack in the Box

$79.66

-0.97 (-1.20%)

16:17
11/19/18
11/19
16:17
11/19/18
16:17
Hot Stocks
Jack in the Box sees FY19 SSS flat to up 2%. »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.